Bayer AG (FRA:BAYN) received a €124.00 ($145.88) price objective from Deutsche Bank AG in a report released on Friday. The firm currently has a “buy” rating on the healthcare company’s stock.

Several other equities research analysts also recently commented on BAYN. Citigroup Inc. set a €130.00 ($152.94) price objective on Bayer AG and gave the company a “buy” rating in a report on Thursday, June 29th. Sanford C. Bernstein set a €128.00 ($150.59) price objective on Bayer AG and gave the company a “buy” rating in a report on Friday, June 30th. DZ Bank AG reissued a “neutral” rating on shares of Bayer AG in a report on Friday, June 30th. Goldman Sachs Group, Inc. (The) set a €125.00 ($147.06) price objective on Bayer AG and gave the company a “buy” rating in a report on Friday, June 30th. Finally, Berenberg Bank set a €121.00 ($142.35) price objective on Bayer AG and gave the company a “neutral” rating in a report on Monday, July 3rd. Eight investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Bayer AG currently has an average rating of “Buy” and an average target price of €122.24 ($143.81).

Bayer AG (FRA BAYN) opened at 111.925 on Friday. The stock has a 50 day moving average of €114.09 and a 200-day moving average of €112.90. Bayer AG has a 52-week low of €85.72 and a 52-week high of €123.83. The company has a market cap of €97.61 billion and a price-to-earnings ratio of 19.361.

COPYRIGHT VIOLATION NOTICE: This story was posted by American Banking News and is the property of of American Banking News. If you are reading this story on another website, it was illegally copied and republished in violation of US and international copyright and trademark laws. The original version of this story can be accessed at https://www.americanbankingnews.com/2017/10/27/bayer-ag-bayn-pt-set-at-124-00-by-deutsche-bank-ag.html.

Bayer AG Company Profile

.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.